Granuflo

which was provided to tens of thousands of kidney dialysis patients across the country but has been linked to sudden cardiac arrest, injury and death among patients. Evidence indicates that Granuflo’s manufacturer, Fresenius Medical Care North America, knew its products posed a deadly risk to patients but kept the dangers a secret, without adequately instructing doctors and healthcare providers on how to use Granuflo in a way to avoid this harm.